메뉴 건너뛰기
Nephrology
Volumn 12, Issue 6, 2007, Pages 620-621
Amyloid a amyloidosis and renal failure in a course of castleman disease
Author keywords

[No Author keywords available]
Indexed keywords

AMYLOID A PROTEIN; INTERLEUKIN 6; PREDNISONE; RECOMBINANT ERYTHROPOIETIN;
EID: 35848961003     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2007.00841.x     Document Type: Article
Times cited : (6)
References (8)
  • 1
    • 0021933846 scopus 로고
    • A systemic lymphoproliferative disorder with morphological features of Castleman disease: Clinical findings and clinicopathological correlation in 15 patients
    • Frizzera G, Peterson BA, Bayrd ED, Goldman A. A systemic lymphoproliferative disorder with morphological features of Castleman disease: Clinical findings and clinicopathological correlation in 15 patients. J. Clin. Oncol. 1985 3 : 1202 16.
    • (1985) J. Clin. Oncol. , vol.3 , pp. 1202-16
    • Frizzera, G.1    Peterson, B.A.2    Bayrd, E.D.3    Goldman, A.4
  • 2
    • 0028959866 scopus 로고
    • End-stage renal failure from renal amyloidosis of the AA type associated with giant lymph node hyperplasia (Castleman disease)
    • Montoli A, Minola E, Stabile F et al. End-stage renal failure from renal amyloidosis of the AA type associated with giant lymph node hyperplasia (Castleman disease). Am. J. Nephrol. 1995 15 : 142 6.
    • (1995) Am. J. Nephrol. , vol.15 , pp. 142-6
    • Montoli, A.1    Minola, E.2    Stabile, F.3
  • 3
    • 0029245765 scopus 로고
    • Secondary amyloidosis associated with Castleman disease
    • Tanaka K, Horita M, Shibayama H et al. Secondary amyloidosis associated with Castleman disease. Intern. Med. 1995 34 : 122 6.
    • (1995) Intern. Med. , vol.34 , pp. 122-6
    • Tanaka, K.1    Horita, M.2    Shibayama, H.3
  • 4
    • 0036933525 scopus 로고    scopus 로고
    • Secondary amyloidosis in Castleman disease: Review of the literature and report of a case
    • Altiparmak MR, Pamuk GE, Pamuk ON, Dogusoy G. Secondary amyloidosis in Castleman disease: Review of the literature and report of a case. Ann. Hematol. 2002 81 : 366 9.
    • (2002) Ann. Hematol. , vol.81 , pp. 366-9
    • Altiparmak, M.R.1    Pamuk, G.E.2    Pamuk, O.N.3    Dogusoy, G.4
  • 5
    • 0020568832 scopus 로고
    • Persistently high serum amyloid a protein and C-reactive protein levels correlate with rapid progression of secondary amyloidosis
    • Falck HM, Maury CPJ, Teppo AM, Wegelius O. Persistently high serum amyloid A protein and C-reactive protein levels correlate with rapid progression of secondary amyloidosis. BMJ 1983 286 : 1391.
    • (1983) BMJ , vol.286 , pp. 1391
    • Falck, H.M.1    Maury, C.P.J.2    Teppo, A.M.3    Wegelius, O.4
  • 6
    • 0031888174 scopus 로고    scopus 로고
    • Castleman's disease and mesangial proliferative glomerulonephritis: The role of interleukin-6
    • Lui SL, Chan KW, Li FK, Cheng IKP, Chan TM. Castleman's disease and mesangial proliferative glomerulonephritis: The role of interleukin-6. Nephron 1998 78 : 323 7.
    • (1998) Nephron , vol.78 , pp. 323-7
    • Lui, S.L.1    Chan, K.W.2    Li, F.K.3    Cheng, I.K.P.4    Chan, T.M.5
  • 7
    • 0024507857 scopus 로고
    • Angiofollicular lymph node hyperplasia with amyloidosis
    • West KP, Morgan DR, Launder I. Angiofollicular lymph node hyperplasia with amyloidosis. Postgrad. Med. J. 1989 65 : 108 11.
    • (1989) Postgrad. Med. J. , vol.65 , pp. 108-11
    • West, K.P.1    Morgan, D.R.2    Launder, I.3
  • 8
    • 0024459013 scopus 로고
    • Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman disease
    • Yoshizaki K, Matsuda T, Nishimoto T et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman disease. Blood 1989 74 : 1360 67.
    • (1989) Blood , vol.74 , pp. 1360-67
    • Yoshizaki, K.1    Matsuda, T.2    Nishimoto, T.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.